KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

AbCellera Biologics (ABCL) Other Operating Expenses: 2020-2023

Historic Other Operating Expenses for AbCellera Biologics (ABCL) over the last 4 years, with Dec 2023 value amounting to $6.7 million.

  • AbCellera Biologics' Other Operating Expenses fell 55.90% to $6.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was $25.7 million, marking a year-over-year decrease of 73.41%. This contributed to the annual value of $91.1 million for FY2024, which is 253.41% up from last year.
  • Per AbCellera Biologics' latest filing, its Other Operating Expenses stood at $6.7 million for Q4 2023, which was up 10.37% from $6.1 million recorded in Q3 2023.
  • AbCellera Biologics' Other Operating Expenses' 5-year high stood at $49.6 million during Q1 2022, with a 5-year trough of $667,000 in Q3 2020.
  • For the 3-year period, AbCellera Biologics' Other Operating Expenses averaged around $15.8 million, with its median value being $9.7 million (2021).
  • Per our database at Business Quant, AbCellera Biologics' Other Operating Expenses skyrocketed by 2,461.13% in 2021 and then slumped by 87.13% in 2023.
  • Quarterly analysis of 4 years shows AbCellera Biologics' Other Operating Expenses stood at $32.7 million in 2020, then dropped by 15.36% to $27.7 million in 2021, then crashed by 44.81% to $15.3 million in 2022, then plummeted by 55.90% to $6.7 million in 2023.
  • Its Other Operating Expenses stands at $6.7 million for Q4 2023, versus $6.1 million for Q3 2023 and $6.5 million for Q2 2023.